1 FTSE 250 stock I’d buy today

The FTSE 250 massively underperformed the FTSE 100 in 2022. But here’s one stock in the out-of-favour index that I’d buy right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

British Isles on nautical map

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 outperformed the FTSE 250 by a wide margin last year. The UK’s blue-chip index ended the year slightly up, while the mid-cap index fell almost 20%. That was its worst performance since 2008.

As such, I’ve been turning my attention to mid-sized companies on the FTSE 250 that might offer me high-growth opportunities. And one defence stock has caught my eye.

Deception and protection

Chemring Group (LSE: CHG) creates advanced technology solutions for defence, security and law enforcement agencies. It also sells into commercial markets such as medical, transport and space (customers include NASA and SpaceX). Its products can be found in more than 50 countries.

The company divides its business into two main segments. First comes Countermeasures and Energetics, which is made up of products used to deceive radar, sonar and other detection systems. For example, military aircraft use such devices to fool ground-to-air missiles. This division also sells aircraft safety components, such as oxygen masks and ejector seats for aircrew.

Its Sensors and Information segment supplies products to detect biological and chemical weapons, as well as software and solutions for electronic warfare. As a consequence of Russia’s invasion of Ukraine, the company sees a growing number of opportunities for its electronic warfare products in the international market.

Business momentum

For the fiscal year ended 31 October 2022, group revenue increased 13% year on year to £442.8m. Its underlying pre-tax profit was up 12% to £62.5m.

Chemring’s order book has expanded significantly, due to heightened geopolitical tensions. It increased 30% year on year, and now stands at £650.9m.

The company was also able to reduce its net debt by 73% during the period, leaving it at just £7.2m.

Finally, the dividend was increased 19% to 5.7p per share. The stock now has a forward dividend yield of 2.3%.

Optimism and risks

The outlook from management is understandably bullish. It said: “Chemring is well placed, with a robust strategy, market-leading positions across different geographies and sectors, and with products and services that are critical to our government and blue-chip customers around the world. Long-term prospects remain strong.”

One risk that should be pointed out is customer concentration. Over 50% of the group’s sales are in the US, while the UK accounts for about 30% of revenue. Any slashing of military budgets here or in the US over the next few years could impact the company’s growth trajectory. That said, the company is diversified across different sectors within both countries.

Also, the stock would presumably take a knock if Russia and Ukraine entered peace negotiations. Sadly, that doesn’t look like happening any time soon.

Beating the FTSE 250

The shares are up 3% over one year, but they’re actually down 21% since May. Over five years, the stock is up 58%, excluding dividends. That’s comfortably ahead of the FTSE 250, which has declined 6% over the same period.

Chemring’s market cap today is £812m, with each share costing 286p. That gives the stock a price-to-earnings (P/E) ratio of about 17. Its price-to-sales ratio (P/S) is 1.8. Neither valuation indicates to me that it’s overpriced.

Overall, I’m encouraged enough to start a position as soon as I have the capital available.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smart young brown businesswoman working from home on a laptop
Investing Articles

Should I be watching the Greatland Gold (LSE: GGP) share price?

Recent rallies in valuable metal prices has boosted the Greatland Gold share price, but is there still an opportunity for…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

The abrdn share price is down 23% in the last year, should I buy?

Asset management firms have had a rough time lately, but with the abrdn share price down heavily, is now the…

Read more »

Hand of a mature man opening a safety deposit box.
Investing Articles

If I’d invested £5k in red hot BAE Systems shares 5 years ago here’s what I’d have today

BAE Systems shares have smashed the FTSE 100 for years and Harvey Jones is keen to buy more as they…

Read more »

Investing Articles

How I’d aim to earn £16,100 in passive income a year by investing £20k in a Stocks and Shares ISA

Harvey Jones is building a portfolio of high-yielding FTSE 100 dividend stocks that should give him a high and rising…

Read more »

Investing Articles

Down 8% in a month! The BP share price is screaming ‘buy, buy, buy’ at me right now 

When crude oil falls, the BP share price invariably follows. Harvey Jones is wondering whether this is the right point…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

Could the 9.8% M&G dividend yield get even bigger?

Christopher Ruane reckons that, although the M&G dividend yield is already close to a double-digit percentage, it could get better…

Read more »

Investing Articles

How much passive income could I earn by putting £380 a month into a Stocks and Shares ISA?

Christopher Ruane explains how he'd aim to turn a Stocks and Shares ISA into four-figure passive income streams each year.

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

2 passive income stocks I’m buying before an interest rate cut

With the market expecting interest rates to fall in August, time might be running out for investors looking to buy…

Read more »